<div class=”d4p-bbt-quote-title”>CaptainMusky wrote:</div>
True, but they are pennies on the dollar because they are off patent right? There are people who understand the drugs formulary far more than me and they drew a strong correlation between Ivermectin and the new Merck therapeutic. One is pennies, the other is $700. Which do you think the company wants to sell more of? How convenient the timing of all the MSM coverage and Merck calling it a “horse dewormer” when days later they announce their new pill?
Just jack the price up just like everything else people need. Nothing is stopping them and they wouldn’t have to pour money into development.
Not to mention the fact that all of these therapeutics can and have been used in conjunction with vaccination. The argument has no merit.
Matt I appreciate you constantly playing contrarian, really I do as you make a lot of valid points. But to pretend there is no difference between off patent drugs that sell for next to nothing, and the printing press of money flowing directly into Pfizer, Moderna, Janssen et al for vaccines and potentially new therapeutics is being willfully obtuse. How about Monoclonal Antibodies? Those are relatively cheap and abundant, yet they are not readily available everywhere despite a consensus on there efficacy. Carrying weight for the suddenly benevolent Big Pharma and Big Govt Agencies (NIH, CDC etc.) is really a weird look imo.